Selective inhibition of interleukin-2 inducible T cell kinase (ITK) enhances anti-tumor immunity in association with Th1-skewing, cytotoxic T cell activation, and reduced T cell exhaustion https://www.biorxiv.org/content/10.1101/2023.07.05.547822v1?med=mas